静脉血栓栓塞和血液与temozolomide-,贝瓦西祖马布和酸尿基治疗在质瘤:一个双数据库药监测研究
Xiaohong Hou1, Yuanlu Zhang1, Cheng Liang1
1Department of Neurosurgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
Cancers
|January 10, 2026
概括
含有贝瓦西祖马布的治疗方法,特别是temozolomide,在恶性质瘤患者中显著增加了静脉血栓栓塞 (VTE) 和胃肠道 (GI) 出血的风险. 单独的泰莫佐洛米德显示VTE风险很小,而酸的安全性数据不确定.
科学领域:
- 药监和药物安全研究.
- 瘤学和神经瘤学治疗方法.
背景情况:
- 恶性质瘤患者面临高风险的静脉血栓栓塞 (VTE) 和出血.
- 对质瘤的全身疗法可以进一步提高血管风险.
研究的目的:
- 为了比较与temozolomide,bevacizumab,lomustine和carmustine相关的静脉瘤,中枢神经系统出血和肠道出血的风险.
- 为了探索基于贝瓦西祖马布的结合疗法治疗质瘤的出血风险.
主要方法:
- 使用FAERS和CVARD数据库进行回顾性药监测研究.
- 对暴露于temozolomide,bevacizumab,lomustine或carmustine的质瘤患者的分析.
- 使用报告概率比率 (RORs) 来识别安全信号的不成比例评估.
主要成果:
- 贝瓦西祖马布显示出对VTE和胃肠道出血的一致的积极信号.
- 泰莫佐洛米德没有显示出明确的VTE信号;酸盐的信号稀疏,不稳定.
- 贝瓦西祖马布 + 泰莫佐洛米德疗法比单独使用贝瓦西祖马布的风险更高,呈现出更高的VTE和GI出血风险.
结论:
- 含有贝瓦西祖马布的疗法,特别是temozolomide,在恶性质瘤中携带了最高的VTE和GI出血负担.
- 在VTE方面,Temozolomide单疗似乎相对中立.
- 对于酸盐的安全信号需要进一步调查.
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:29Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196
01:30Venous Thrombosis IV: Nursing Management
192
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
192
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
801
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
801
01:29Venous Thrombosis III: Interprofessional Care
276
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
276
01:16Therapeutic Drug Monitoring: Overview and Classification
304
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
304